Analyst ratings, especially from prominent firms like HC Wainwright and Goldman Sachs, can significantly influence investor sentiment and stock prices. The maintenance of a Buy rating combined with increased price targets suggests a strong positive outlook for SpringWorks Therapeutics, which is likely to encourage investor confidence and could lead to a short-term increase in the stock price.